Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

BioCryst advances phase I study of BCX-9930 for paroxysmal nocturnal hemoglobinuria

Oct. 29, 2019

Grant supports clinical trial of personalized treatment approach for aplastic anemia

Oct. 23, 2019

Ultomiris approved in U.S. for atypical hemolytic uremic syndrome

Oct. 21, 2019

Shanghai Meiyue Biotech Development discovers thrombin and factor XIa inhibitors

Oct. 18, 2019

Principia Biopharma reports preliminary data from phase I/II trial of PRN-1008 in ITP

Oct. 16, 2019

Heterozygous mouse model of VWD associated with dominant-negative mutations

Oct. 11, 2019

FDA approves Wilate for hemophilia A

Oct. 9, 2019

Discovery of novel potent fully human FVIII mimetic BiAb, KY-1049

Oct. 9, 2019

BARDA contract supports Platelet BioGenesis' development of donor-independent platelets

Oct. 8, 2019

Phase I study of CSL-200 gene therapy in adults with severe sickle cell disease

Oct. 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...